Gastrointestinal perforation associated with bevacizumab in metastatic colorectal cancer

Gastrointestinal perforation associated with bevacizumab in metastatic colorectal cancer

Abstract Objective To investigate the risk factors for gastrointestinal perforation in metastatic colorectal cancer patients receiving bevacizumab. Methods We retrospectively reviewed 217 patients with metastatic colorectal cancer receiving bevacizumab to investigate the risk factors for gastrointes...

Full description

Bibliographic Details
Main Authors: Kunpeng Fang, Jie Wang, Jianyong Yuan, Chengjun Sui, Jiajun Zhi, Yong Xia, Minmin Sun
Format: Article
Language:English
Published: Wiley 2024-02-01
Series:Cancer Reports
Subjects:
adverse reactions
bevacizumab
colorectal cancer
gastrointestinal perforation
Online Access:https://doi.org/10.1002/cnr2.1952

Internet

https://doi.org/10.1002/cnr2.1952

Similar Items